Siemens Aktiengesellschaft

Apeptico Forschung Und Entwicklung Gmbh

Baxter Aktiengesellschaft

Immuno Aktiengesellschaft

Siemens Automotive Corporation

Baxter Innovations Gmbh

Other

Vacuumschmelze Gmbh

Siemens Ag Osterreich

Bio-products & Bio-engineering Ag

Bernhard Fischer

Friedrich Dorner

Artur Mitterer

Andreas Kappel

Johann J Eibl

Bernhard Gottlieb

Georg Bachmaier

Enrico Ulivieri

Rudolf Lucas

Hans Meixner

Uwe Schlokat

Peter Turecek

Hans-Peter Schwarz

Randolf Mock

Falko-Guenter Falkner

Tim Schwebel

Manfred Reiter

Wolfgang Mundt

Jack R Lorraine

Martin Matschnig

Hendrik Fischer

Renate Den-Bouwmeester

Gerit Ebelsberger

Bernhard Roas

Stefan Kautz

Michael Höge

Kathrin Thomas-Urban

Christian Fiedler

Herbert Taucher

Thomas Hinterstoisser

Christian Tump

Jens Mueller

Christian Cech

Susan Jane Tzotzos

&Ouml;yvind L Sch&ouml;nberger

Juergen Siekmann

Eric Chemisky

Matthias Gerlich

Arnold Meyer

Erhard Magori

Thomas Schmid

Wolfgang Zöls

Dominik Bergmann

Jingming Jim Shen

Majid Ghameshlu

Stefan Lehmann

Friedrich Eppensteiner

Falko-Gunter Falkner

Johann Görzen

Frank Herold

Wilhelm Meyrath

Helmut Pietschmann

Oyvind L Schönberger

Öyvind L Schönberger

Amandus Kofler

Manfred K&uuml;hnl

Helmut Helld&ouml;rfer

Jens M&uuml;ller

Helmut Helldoerfer

Arthur Mitterer

Anita Willam

Susan Tzotzos

Dusan Tomic

Joubin Djavan

Rosa Lemmens-Gruber

Waheed Shabbir

A method of conditioning/improving lung functions extracorporeally by treatment of a non-ischemic donor lung ex vivo with a cyclized compound of the amino acid sequence of formulaX-GQRETPEGAEAKPWY-X  I

Pharmaceutical composition comprising a cyclic peptide of formula X1-GQRETPEGAEAKPWY-X2 and use for extracorporeal lung treatment

A peptide is described, which consists of 7-17 adjacent amino acids and comprises the hexamer TXEXXE, wherein X, X and X can be any natural or non-natural amino acid, wherein the peptide has no TNF receptor binding activity and is cyclized, for the prevention and treatment of hyperpermeability of epithelial cells and endothelial cells.

Method for preventing and treating hyperpermeability

A method for managing licenses for soft IP on a partially reconfigurable hardware system, in particular an FPGA, wherein a license manager is provided in the non-configurable part of the hardware system, or is accessible only for the non-configurable part of the hardware system, where the license manager has exclusive access to a non-volatile memory in which license data having a time restriction of the useful life of at least one soft IP is stored, where before activating a particular soft IP, the license manager checks whether the useful life has expired, where the license manager only releases use of the soft IP if the useful life has not yet expired, where the license data is changed using a key, which is stored in a non-volatile memory for license data, and where a new key is stored and the preceding key is deleted when the license data is changed.

Method for managing soft IP licenses on a partially reconfigurable hardware system

A system and method for the predictive maintenance of electronic components that includes sensors at at least one position via which present values of system parameters, such as temperature and voltage, and a signal propagation time at the at least one position are determined, where values of the system parameters and the signal propagation time presently determined by the sensors are retrieved by a central monitoring unit, an individual valid limit value is determined for the signal propagation time at each of the at least one position via the central monitoring unit based on the presently determined values of the system parameters, and the presently determined signal propagation time at each of the at least one position is compared with the associated valid limit value, and a notification is sent to a superordinate level, if the signal propagation time exceeds the limit value to trigger replacement of the electronic component.

Method and system for predictive maintenance of integrated circuits

Described is a composition comprising a peptide which consists of 7-17 adjacent amino acids and comprises the hexamer TXEXXE, where X, X, and Xcan be any natural or non-natural amino acid, and the peptide is cyclized and does not exhibit TNF receptor binding activity, and an inhibitor of viral neuraminidase.

Composition comprising a peptide and an inhibitor of viral neuraminidase

Disclosed is a dry-powder peptide medicament with a non-typical concentration of carbohydrate excipient, as well as said medicament for use in treatment or prevention of a disease or condition, as well as methods for manufacturing said medicament.

Dry-powder peptide medicament

Cyclic peptide of formula whereinXcomprises an amino acid (sequence), with 1 to 4 members, comprising natural and unnatural amino acids, and Xcomprises a natural amino acid, and wherein Xcomprises the N-terminal amino acid left in position 1, and Xthe C-terminal amino acid in the ultimate, right position, in the form of a lyophilisate without additives and/or stabilizers and its use.

Lyophilisate containing a cyclic peptide of formula X-GQRETPEGAEAKPWY-X

Described is a composition comprising&#x2014;a peptide which consists of 7-17 adjacent amino acids and comprises the hexamer TXEXXE, where X, Xand Xcan be any natural or non-natural amino acid, and the peptide is cyclized and does not exhibit TNF receptor binding activity, and&#x2014;an inhibitor of viral neuraminidase.

A method for determining system reliability of a logic circuit, wherein a functional component model for design/simulation of a circuit model of the logic circuit is created, where functional components model are expanded by adding an associated power model, a temperature model, and a reliability, where the logic circuit is constructed with expanded model components and, based on simulation of the logic circuit aided by the constructed circuit model, a functional, a power-dependent, and a temperature-dependent behavior and a temperature-dependent failure rate are derived for each component in a component specific manner for a specified application case, and where in addition to the functional behavior, a power and temperature behavior and a total failure rate can be determined simply and dynamically, based on the derived data and dependent on temperature and simulation time for the logic circuit for the specified application case.

Method for determining system reliability of a logic circuit

A method for a logic circuit including a plurality of components and channels which are each assigned functional properties in a circuit model to simulate how the logic circuit functions, where the circuit model, in a section of the method, is expanded by mechanisms for security analysis, and where in a further section of the method, the following method steps are implemented via a simulation unit, i.e., check whether the security property of the respective component and/or the respective channel corresponds to the security requirement of the security-relevant data and generate a security risk report if it does not correspond thereto, apply a modeled attack to a component and/or to a channel, and determine a vulnerability of the security property of the respective component and/or of the respective channel to the applied attack, and if there is vulnerability of the security property, generate an attack report.

Method for analyzing a logic circuit

What is described is a peptide which consists of 7-20, especially 7-17, adjacent amino acids and comprises the hexamer TXEXXE where X, Xand Xmay be any natural or unnatural amino acid, where the peptide does not have any TNF receptor binding activity and is cyclized, for use for the treatment and avoidance of the pulmonary form of altitude sickness.

Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressure

In addition to liquid in a thermal volume-neutral stroke transmitter, first and/or second displacement body(ies) is/are positioned in the stroke transmitter, for displacing the liquid. These three materials in the closed system are designed so that the stroke transmitter remains pressure-free during temperature changes.

Thermally volume-neutral stroke transmitter, in particular for metering valve without hydraulic compensator

The hydraulic temperature compensator has at least one longitudinally extensible hydraulic chamber and a gas-filled chamber which is at least partly enclosed by the hydraulic chamber, wherein the hydraulic chamber is subdivided into a first sub-chamber and a second sub-chamber which are hydraulically connected to each other by at least one throttle point and wherein the second sub-chamber adjoins the gas-filled chamber. The stroke transmitter has at least the hydraulic temperature compensator, a stroke actuator acting on the temperature compensator, and a further hydraulic chamber which is fluidically connected to the first sub-chamber of the hydraulic chamber of the temperature compensator, wherein the further hydraulic chamber is in fluidic connection with a displaceably mounted actuating element.

Hydraulic temperature compensator and hydraulic lift transmitter

A peptide consisting of 7-17 amino acids and including the adjacent hexamer TXEXXE, where X, Xand Xcan be any natural or non natural amino acid, wherein the peptide does not exhibit TNF-receptor-binding activity and is cyclic, for the treatment or prevention of vascular complications in diabetes patients.

Treatment of vascular complications of diabetes

A stroke translator or an injector having a solid-state actuator for generating a stroke and a hydraulic system for the hydraulic transmission of the stroke of the solid-state actuator to a control element such as a jet needle of a valve. The hydraulic system has hydraulic volumes hermetically sealed to the outside by metal bellows and constitute a hydraulic bearing with compensation for play. The advantages over known hydraulic levers are such that a complete metal seal is provided, and that a lower-wear design can be realized. Furthermore, a modular structure can be produced.

Hydraulic stroke transmitter

Growing community of inventors

Vienna, Austria

Bernhard Fischer